Keeping an eye on your blood pressure is about to get much easier and more efficient, thanks to a new version from OMRON Healthcare, Inc.
OMRON has sold a wide variety of home care products for years, including its popular blood pressure monitors that you can find just about anywhere. Now they are bringing this into the 21st century.
OMRON has created VitalSight, a remote patient monitoring program, for high-risk hypertensive patients. It is an easy-to-use service that physicians can use to enroll patients with high-risk levels of hypertension or uncontrolled hypertension. Patients receive a kit delivered directly to their home.
The kit includes a blood pressure monitor connected to OMRON and a predefined data concentrator to securely share measurements with the patient’s physician and healthcare team. VitalSight’s data can be integrated directly into their existing electronic medical record (EMR) system or through the OMRON Doctor dashboard.
Doctors are notified if their preselected blood pressure thresholds are reached and send automatic notifications through the EMR that signal when a patient has readings indicating whether action is needed.
“The statistics for hypertension are remarkable in the United States and around the world,” said Bill Fillipp, head of marketing and brand communications. “The American Heart Association estimates that nearly 116 million American adults are hypertensive, and the CDC reports that 37 million of them have uncontrolled stage 2 hypertension, which means they are at greater risk. high heart attack and stroke. OMRON created VitalSight for high risk hypertensive patients. The objective is that it leads to a more active management of the state of health and to a greater dialogue between the patient and the doctor. “
Fillipp pointed out one aspect that excites OMRON is its availability at little or no cost to patients, depending on their Medicare coverage.
VitalSight launched at CES 2021 in January and has since partnered with major medical institutions across the country. The system is currently in pilot programs at Mount Sinai Hospital in New York and Northwestern Medicine in Chicago.
“Early physician feedback shows VitalSight is rapidly helping physicians improve engagement with patients on their treatment plans,” Fillipp said. “This is OMRON’s latest offering that contributes to our corporate mission of Going for Zero – eliminating heart attacks and strokes. “
Fillipp knows the goal is ambitious, but said the company is constantly striving to get closer and closer to that number through more innovative products and services.
OMRON is a Japanese company with local operations in various locations around the world and products reaching 120 countries. In 2020, the company reported $ 5.9 billion in global sales. OMRON also has corporate skills that extend to other industries, including industrial automation, social systems, environmental solutions, and mechanical components.
OMRON was established in 1933 as Tateisi Electric Manufacturing Co. when the company started producing X-ray timers. ■